Want to see NIKI full AI Analyst Report?
Niki BioSolutions Inc (NIKI) Financial Statements
Niki BioSolutions Inc Financial Overview
Niki BioSolutions Inc's market cap is currently $5.52M. The company's EPS TTM is $-4.20; its P/E ratio is -0.09; Niki BioSolutions Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 431.38K | $ 1.30M | $ 1.54M |
| Gross Profit | $ 0.00 | $ -255.00K | $ 10.57K | $ 80.06K | $ 81.85K |
| Operating Income | $ -1.82M | $ -3.80M | $ -10.60M | $ -17.51M | $ -19.21M |
| EBITDA | $ -1.82M | $ -3.71M | $ -9.22M | $ -9.97M | $ -25.83M |
| Net Income | $ -1.36M | $ -4.27M | $ -2.83M | $ -9.80M | $ -25.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.45M | $ 874.24K | $ 2.01M | $ 1.99M | $ 8.50M |
| Total Assets | $ 18.69M | $ 16.13M | $ 20.64M | $ 20.87M | $ 21.91M |
| Total Debt | $ 3.44M | $ 3.35M | $ 3.28M | $ 6.85M | $ 217.17K |
| Net Debt | $ -9.96K | $ 2.48M | $ 1.28M | $ 4.97M | $ -7.91M |
| Total Liabilities | $ 4.90M | $ 4.35M | $ 5.26M | $ 13.03M | $ 4.40M |
| Stockholders' Equity | $ 23.16M | $ 21.13M | $ 24.85M | $ 15.71M | $ 23.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.84M | $ -1.19M | $ -7.73M | $ -12.51M | $ -14.79M |
| Operating Cash Flow | $ -1.84M | $ -1.19M | $ -7.72M | $ -12.32M | $ -14.65M |
| Investing Cash Flow | $ 0.00 | $ 58.62K | $ 624.77K | $ 2.44M | $ 16.51M |
| Financing Cash Flow | $ 4.42M | $ 0.00 | $ 4.09M | $ 6.63M | $ 2.78M |
Currency in USD